Intrinsic Value

RGIN doesn't have a meaningful market cap.
Not Available for RGIN

There is not enough data to reliably calculate the intrinsic value for Regenicin Inc.

Do our valuations actually work? See backtest results .

Alternatives to RGIN

Fundamental Analysis

What Regenicin Does

Regenicin, Inc. is a biotechnology company, which specializes in the development of regenerative cell therapies to restore the health of damaged tissues and organs. The company is headquartered in Las Vegas, Nevada and currently employs 3 full-time employees. The company went IPO on 2008-05-12. The firm is focused on developing and commercializing a lifesaving technology through the introduction of tissue-engineered skin substitutes to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds and a range of plastic surgery procedures.

Headquarters
United States of America US
Employees
3
IPO date
May 12, 2008
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Regenicin Inc

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape